(NYSE: TRLV) Trulieve Cannabis's forecast annual revenue growth rate of -15.29% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 12.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.27%.
Trulieve Cannabis's revenue in 2026 is $1,170,174,000.On average, 9 Wall Street analysts forecast TRLV's revenue for 2026 to be $194,807,137,885, with the lowest TRLV revenue forecast at $186,161,008,646, and the highest TRLV revenue forecast at $201,730,195,105. On average, 8 Wall Street analysts forecast TRLV's revenue for 2027 to be $180,745,639,443, with the lowest TRLV revenue forecast at $169,387,979,459, and the highest TRLV revenue forecast at $190,320,612,192.
In 2028, TRLV is forecast to generate $100,313,176,046 in revenue, with the lowest revenue forecast at $22,878,781,041 and the highest revenue forecast at $182,012,943,528.